[Federal Register Volume 81, Number 27 (Wednesday, February 10, 2016)]
[Notices]
[Pages 7143-7144]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-02691]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-969]


Certain Blood Cholesterol Test Strips and Associated Systems 
Containing the Same; Commission's Determination Not To Review an 
Initial Determination Terminating the Investigation; Termination of the 
Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to

[[Page 7144]]

review the presiding administrative law judge's (``ALJ'') initial 
determination (``ID'') (Order No. 8) granting a joint motion to 
terminate the investigation.

FOR FURTHER INFORMATION CONTACT: Amanda Pitcher Fisherow, Esq., Office 
of the General Counsel, U.S. International Trade Commission, 500 E 
Street SW., Washington, DC 20436, telephone (202) 205-2737. Copies of 
non-confidential documents filed in connection with this investigation 
are or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its Internet server at http://www.usitc.gov. The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at http://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on November 5, 2015, based on a complaint filed on behalf of Polymer 
Technology Systems, Inc. of Indianapolis, Indiana (``Complainant''). 80 
FR 68563 (Nov. 5, 2015). The complaint alleged violations of Section 
337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the sale 
for importation or sale within the United States after importation of 
certain blood cholesterol test strips and associated systems containing 
same by reason of infringement of certain claims of U.S. Patent No. 
7,087,397. The notice of investigation named Infopia Co., Ltd. of 
Gyeonggi-do, Korea; Infopia America LLC of Titusville, Florida; and 
Jant Pharmacal Corporation of Encino, California as respondents. The 
Office of Unfair Import Investigations was also named as a party but 
later withdrew from the investigation.
    On January 19, 2016, the private parties filed a joint motion to 
terminate the investigation based on a settlement agreement.
    On January 20, 2016, the ALJ granted the joint motion to terminate. 
The ALJ found the parties included confidential and public versions of 
the settlement agreement and that the parties represented that there 
are no other agreements, written or oral, express or implied concerning 
the subject matter of the investigation. The ALJ also found that 
termination of the investigation is not contrary to the public 
interest. No petitions for review were filed.
    The Commission has determined not to review the subject ID.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
part 210).

    Issued: February 5, 2016.

    By order of the Commission.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016-02691 Filed 2-9-16; 8:45 am]
 BILLING CODE 7020-02-P